Replies to post #4334 on Phio Pharmaceuticals Corp (PHIO)

[realfast95]

Cool tool, thanks. Got it.


Co-Founder
2015 - Current
Mirimmune, Inc.
MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA.